Food News and Research

RSS

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

News outlets analyze the impact that generic Lipitor could have on costs and the "era of 'blockbuster drugs'" as well as the strategies from Lipitor's maker to block its generic competitors. Meanwhile, some of these generics are already reaching the marketplace.

2 Dec 2011

Arbor files first NDA with U.S. FDA

Arbor Pharmaceuticals announced today that it has filed its first New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The recently filed product has been granted an Orphan designation by the FDA which provides seven years of market exclusivity.

2 Dec 2011

Mylan confirms generic Generess Fe patent challenge

Mylan Inc. today confirmed that it and Famy Care Ltd. have been sued by Warner Chilcott Company LLP, in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets, 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This product is the generic version of Generess Fe, a 28-day regimen indicated for use by women to prevent pregnancy.

2 Dec 2011

Idera receives FDA notification to proceed with IMO-3100 Phase 2 clinical trial for psoriasis

Idera Pharmaceuticals, Inc. today announced the receipt of verbal notification from the Food and Drug Administration that the company may proceed with a Phase 2 clinical trial of IMO-3100 in patients with psoriasis based on a trial protocol submitted by the company in October 2011.

2 Dec 2011

ADVENTRX, FDA discuss ANX-188 development plans for treatment of sickle cell crisis

ADVENTRX Pharmaceuticals, Inc. announced today that it met with the U.S. Food and Drug Administration (FDA) to review development plans for ANX-188 (purified poloxamer 188), the Company's first-in-class treatment for sickle cell patients experiencing vaso-occlusive crisis.

1 Dec 2011

Republicans advance plan to charge wealthy beneficiaries more for Medicare to offset cost of payroll tax extension

The proposal would require people who earn more than $1 million to pay the full cost of Medicare. Meanwhile, House Majority Leader Eric Cantor, R-Va., is floating a "trigger bargain" that would delay for one year the automatic spending cuts scheduled to begin in 2013 and also could include a payroll tax extension and a fix for physician's Medicare payment rate.

1 Dec 2011

FDA clears Covidien's SpiderFX embolic protection device

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.

1 Dec 2011

First Edition: December 1, 2011

In today's headlines, Republicans in Congress advance plan to charge wealthy beneficiaries more for Medicare in order to cover the costs of the proposaed payroll tax extension.

1 Dec 2011

Publicly posting enforcement and testing data on meat processing facilities could be beneficial

Publicly posting enforcement and testing data corresponding to specific meat, poultry, and egg products' processing plants on the Internet could have "substantial benefits," including the potential to favorably impact public health, says a new report from the National Research Council.

1 Dec 2011

Botulism toxins could be re-engineered for treating RA, asthma, psoriasis

The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping millions of people with rheumatoid arthritis, asthma, psoriasis and other diseases, scientists are reporting. Their study appears in ACS' journal Biochemistry.

1 Dec 2011

Study reveals no clear advantage of one implant type over another

More than 270,000 Americans get hip replacement surgeries every year -- a number that is projected to double in the next decade as the population ages. With various options for implants, including metal-on-polyethylene, metal-on-metal and ceramic-on-ceramic, there have been questions about which kind works best.

1 Dec 2011

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound.

1 Dec 2011

Study finds unhealthy food environment in children's hospitals

Given the obesity epidemic among the nation's young, one would hope that children's hospitals would serve as a role model for healthy eating. But hospitals in California fall short, with only 7 percent of entrees classified as "healthy" according to a new study published in Academic Pediatrics.

1 Dec 2011

Study to explore food safety practices in domestic kitchens across UK

Researchers at the Universities of Hertfordshire and Newcastle have been commissioned by the Food Standards Agency (FSA) to look at food safety practices in UK kitchens.

1 Dec 2011

Radiation can be used to effectively sterilize light brown apple moth

A new study published in the Journal of Economic Entomology shows that radiation can be used to effectively sterilize the light brown apple moth (LBAM), an insect pest found in Australia, New Zealand, California, Hawaii, Sweden, and the British Isles.

1 Dec 2011

Clinton, Ban make remarks at high-level forum on aid effectiveness in South Korea

Speaking at the High-Level Forum on Aid Effectiveness (HLF 4) in Busan, South Korea, "U.S. Secretary of State Hillary Clinton said Wednesday that programs to help the world's poor should be treated as national security priorities as economic turmoil leaves millions struggling to find work and food," the Associated Press reports.

1 Dec 2011

Ranbaxy receives FDA approval to manufacture and market generic Lipitor

Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.

1 Dec 2011

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor.

30 Nov 2011

FDA clears Abbott's new ARCHITECT 25-OH Vitamin D assay

Abbott announced today it has received clearance from the U.S. Food and Drug Administration for a fully-automated 25-OH Vitamin D assay performed on its widely used ARCHITECT laboratory testing platform.

30 Nov 2011

Pfizer backs its highest grosser Lipitor

Pfizer’s Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the market the company has devised discounts and incentives for patients, insurers and companies that process prescriptions that will, at least for the next six months, make the brand name drug about as cheap as or cheaper than the generics.

30 Nov 2011

Food News and Research

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

Arbor files first NDA with U.S. FDA

Mylan confirms generic Generess Fe patent challenge

Idera receives FDA notification to proceed with IMO-3100 Phase 2 clinical trial for psoriasis

ADVENTRX, FDA discuss ANX-188 development plans for treatment of sickle cell crisis

Republicans advance plan to charge wealthy beneficiaries more for Medicare to offset cost of payroll tax extension

FDA clears Covidien's SpiderFX embolic protection device

First Edition: December 1, 2011

Publicly posting enforcement and testing data on meat processing facilities could be beneficial

Botulism toxins could be re-engineered for treating RA, asthma, psoriasis

Study reveals no clear advantage of one implant type over another

Immune system stimulant used as suppressor to treat chronic graft-versus-host disease

Study finds unhealthy food environment in children's hospitals

Study to explore food safety practices in domestic kitchens across UK

Radiation can be used to effectively sterilize light brown apple moth

Clinton, Ban make remarks at high-level forum on aid effectiveness in South Korea

Ranbaxy receives FDA approval to manufacture and market generic Lipitor

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

FDA clears Abbott's new ARCHITECT 25-OH Vitamin D assay

Pfizer backs its highest grosser Lipitor

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News